Rapid Micro Biosystems, Inc. (RPID) stock
RPIDNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 7/3057% below fair value
$0.65−0.02 (-2.98%)
Close on Nov 13, 2026Market cap $32.65MP/E –Yield –
Rapid Micro Biosystems price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Rapid Micro Biosystems's price to sales ratio was 1.0× on Nov 11, 2026, against 6.1× a year earlier. Over the last 4 years it ranged from 0.4× to 6.4×, with a median of 2.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.0× | −3.2 |
| 2025 | Dec 31, 2025 | 4.2× | +2.7 |
| 2024 | Dec 31, 2024 | 1.5× | −0.1 |
| 2023 | Dec 29, 2023 | 1.5× | −1.3 |
| 2022 | Jan 31, 2022 | 2.8× | −1.4 |
| 2021 | Dec 31, 2021 | 4.2× | – |
See a number that looks wrong?